Nektar Therapeutics

Healthcare

NASDAQ:NKTR · NASDAQ Global Select

Market Cap $1.16B Beta 1.15 P/E (TTM) -9.3

$60.98 -2.04%

-$1.24 today

52W Low $8.27High $109.00

Vol 0.81M · Avg 1.00M

EPS (TTM) -$6.39Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+539.20%

Period High

$100.35

Period Low

$9.54

Latest

$60.98

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Relay Therapeutics, Inc.

NASDAQ:RLAY

$2.79B

Enliven Therapeutics, Inc.

NASDAQ:ELVN

$2.72B

Syndax Pharmaceuticals, Inc.

NASDAQ:SNDX

$1.68B

Atai Beckley Inc.

NASDAQ:ATAI

$1.47B

Inhibrx Biosciences, Inc.

NASDAQ:INBX

$1.34B

Immatics N.V.

NASDAQ:IMTX

$1.30B

Amylyx Pharmaceuticals, Inc.

NASDAQ:AMLX

$1.28B

Xencor, Inc.

NASDAQ:XNCR

$930.11M

ORIC Pharmaceuticals, Inc.

NASDAQ:ORIC

$880.42M

Sana Biotechnology, Inc.

NASDAQ:SANA

$850.18M

What is the latest NKTR filing?

The latest filing shown is 4 dated Jun 17, 2026.

How many recent filings does NKTR have?

Intrinsic Alpha currently shows 20 recent filings for NKTR.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.